Glucagon-like peptide-1 receptor agonists for type 2 diabetes

While there are several drug classes available for treating type 2 diabetes, the glucagon-like peptide-1 (GLP-1) receptor agonists are one of the newer classes of pharmacological agents. By Carrie Stewart, pharmacist diabetes educator Learning Objectives After completing this activity pharmacists should be able to: describe the pharmacology and pathophysiology of GLP-1 receptor agonists; discuss where

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?